This invention relates to a method of modulating the expression of a target gene in an organism comprising administering an iRNA agent, wherein the iRNA comprises at least one 2'-deoxy-2'-fluoro (2'-F) nucleotide in the antisense strand and at least one modified nucleotide in the sense strand. The invention also relates to compositions comprising a single-stranded oligonucleotide that contains at least one 2'-deoxy-2'-fluoro (2'-F) nucleotide. siRNA molecule containing these oligonucleotides have decreased immunogenicity.
申请公布号
WO2009142822(A2)
申请公布日期
2009.11.26
申请号
WO2009US38433
申请日期
2009.03.26
申请人
ALNYLAM PHARMACEUTICALS, INC.;MANOHARAN, MUTHIAH;RAJEEV, KALLANTHOTTATHIL, G.